- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Big Pharma Weighs Role in ACOs
Pharmaceuticals companies continue to weigh options for their role in Accountable Care Organizations (ACOs).
Pharmaceuticals companies continue to weigh options for their role in Accountable Care Organizations (ACOs). As with other collaborators, they are deliberating ways they can best reduce costs and improve quality. MedCity News reports:
Like Will Rogers, Dr. David Nash is reluctant to predict the future. But when prodded, the dean of Jefferson’s School of Population Health described a post Accountable Care Act world in which pharmaceutical options will be dictated by outcomes and value. Pharmaceutical companies are trying to figure out the best way they can reduce costs and generate revenue.
“We’re going to see more emphasis on the cost effectiveness and cost benefit of products. Clearly any provider organization that’s going at economic risk…will care a lot more in 2015, 2016 about the economics of the pharma products they are using..We are in need of better population based data.”
The panel discussion at the CONVERGE conference in Philadelphia this week highlighted some interesting ways pharmaceutical companies can respond to these needs by Accountable Care Organizations and what else they can do to add value.
Read the full story: http://bit.ly/14KUjrI
CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity
December 2nd 2024The 6-year mandatory Increasing Organ Transplant Access Model aims to boost kidney transplants and address disparities by incentivizing hospitals, enhancing care coordination, and measuring transplant outcome performance.
Read More
Medicare Competitive Bidding Program Cuts Spending Without Impacting COPD Outcomes
November 29th 2024While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or clinical outcomes among patients with chronic obstructive pulmonary disease (COPD).
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
